Current Issue 28 October 2011, Vol. 239, No. 1

Issue Highlights

  • Targeting Toll-like receptors: Emerging therapeutics for multiple sclerosis management
    28 October 2011(Vol. 239 | No. 1 | Pages 1-12)

    M. Gambuzza, N. Licata, E. Palella, D. Celi, V. Foti Cuzzola, D. Italiano, S. Marino, P. Bramanti

  • Role of glial cells in innate immunity and their role in CNS demyelination
    28 October 2011(Vol. 239 | No. 1 | Pages 13-20)

    Subramaniam Sriram

  • Immune-mediated myelitis associated with Hepatitis virus infections
    28 October 2011(Vol. 239 | No. 1 | Pages 21-27)

    Joerg-Patrick Stübgen

  • Data integration and systems biology approaches for biomarker discovery: Challenges and opportunities for multiple sclerosis
    27 January 2012

    Pablo Villoslada, Sergio Baranzini

  • Key role of CXCL13/CXCR5 axis for cerebrospinal fluid B cell recruitment in pediatric OMS
    24 January 2012

    Michael R. Pranzatelli, Elizabeth D. Tate, Nathan R. McGee, Anna L. Travelstead, Richard M. Ransohoff, Jayne M. Ness, Jerry A. Colliver

  • Elevation of serum TNF-α levels in mild and moderate Alzheimer patients with daytime sleepiness
    24 January 2012

    Rui Chen, You Yin, Zhongxin Zhao, Liuqing Huang, Shuqi Huang, Jianhua Zhuang, Huijuan Wu, Hua Peng, Peng Li

  • Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis
    20 January 2012

    L. Lisi, P. Navarra, R. Cirocchi, A. Sharp, E. Stigliano, D.L. Feinstein, C. Dello Russo

  • Meningothelial cells participate in immunological processes in the cerebrospinal fluid
    20 January 2012

    Bin Fan, Giovanna Bordigari, Josef Flammer, Hanspeter E. Killer, Peter Meyer, Albert Neutzner

  • View More Articles in Press...

On the Cover

Cover Image

Journal Access

Full-text articles are available from 1999 to the present. Access to abstracts is complimentary. Access to full text is limited to ISNI members. Register or login to:

Buy a Subscription Now

Activate Online Access

Publishing Information

Journal of Neuroimmunology is published by Elsevier for the International Society of NeuroImmunology.

Elsevier
Journal Home
Access this journal onSciVerse ScienceDirect
Print or Share This Page

About Journal of Neuroimmunology

The Journal of Neuroimmunology affords a forum for the publication of works applying immunologic methodology to the furtherance of the neurological sciences. Studies on all branches of the neurosciences, particularly fundamental and applied neurobiology, neurology, neuropathology, neurochemistry, neurovirology, neuroendocrinology, neuromuscular research, neuropharmacology and psychology, which involve either immunologic methodology (e.g. immunocytochemistry) or fundamental immunology (e.g. antibody and lymphocyte assays), are considered for publication. Works pertaining to multiple sclerosis, AIDS, amyotrophic lateral sclerosis, Guillain Barré Syndrome, myasthenia gravis, and brain tumors form a major focus. The scope of the Journal is broad, covering both research and clinical problems of neuroscientific interest.

A major aim of the Journal is to encourage the development of immunologic approaches to analyse in further depth the interactions and specific properties of nervous tissue elements during development and disease.

ISNI Information

The purpose of the International Society of NeuroImmunology is:

  • To further the knowledge of neuroimmunologic mechanisms and to apply them to human disease.
  • To encourage the generation and interchange of ideas and scientific data of relevance to the human nervous system development and disease, between basic and clinical scientists engaged in research in the field.
  • To sponsor and conduct symposia for General Members and persons interested in or engaged in research in the field.
  • To provide a central information service to distribute material related to the field, and to publish printed matter related to neuroimmunology, including by association of the Society with the Journal of Neuroimmunology.